Koichi Saruwatari
Chuo, 8608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Clinical significance of 18F-FDG uptake in interstitial lung lesions in lung cancer patients with interstitial lung disease treated with immune checkpoint inhibitor therapy.
Journal: Respiratory investigation
Published: January 16, 2026
Response to trastuzumab deruxtecan in postoperative recurrent lung adenocarcinoma harboring concurrent EGFR and HER2 mutations after progression on adjuvant osimertinib.
Journal: Respiratory investigation
Published: December 16, 2025
Selpercatinib-Associated Nephropathy in RET Fusion-Positive Lung Cancer: A Case Successfully Managed With Dose Adjustment and Nephroprotective Therapy.
Journal: Clinical lung cancer
Published: August 06, 2025
Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 30, 2025
Rapid Emergence of Small-cell Carcinoma Due to Malignant Transformation or de novo Formation in the Anterior Mediastinum Following Thymoma Resection: The Importance of a Re-biopsy.
Journal: Internal medicine (Tokyo, Japan)
Published: December 25, 2024
Durable Response of Pembrolizumab for EGFR Mutation-positive Lung Adenocarcinoma with Early Progression to Osimertinib in First-line Treatment.
Journal: Internal medicine (Tokyo, Japan)
Published: July 10, 2024
Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer.
Journal: Respiratory investigation
Published: June 20, 2024
Pulmonary Tumor Embolism due to Oropharyngeal Carcinoma Diagnosed by a Transbronchial Lung Biopsy.
Journal: Internal medicine (Tokyo, Japan)
Published: May 29, 2024
18F-FDG accumulation at the early onset of acute exacerbation of idiopathic interstitial pneumonia on 18F-FDG PET/CT: A case report.
Journal: Respirology case reports
Published: May 17, 2024
A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902).
Journal: Thoracic cancer
Published: March 23, 2024
Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.
Journal: Clinical lung cancer
Published: February 18, 2024
Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations.
Journal: Cancers
Published: December 01, 2023
Last Updated: 09/26/2026